Edition:
United States

Obalon Therapeutics Inc (OBLN.OQ)

OBLN.OQ on NASDAQ Stock Exchange Global Market

1.62USD
10:36am EST
Change (% chg)

$-0.08 (-4.71%)
Prev Close
$1.70
Open
$1.58
Day's High
$1.63
Day's Low
$1.58
Volume
14,299
Avg. Vol
22,818
52-wk High
$8.10
52-wk Low
$1.46

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.38 December 17 Dec 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 2 2 2 2
(3) HOLD 2 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 6 2.33 3.00 1.90 7.55
Quarter Ending Mar-19 5 2.72 3.00 2.30 1.60
Year Ending Dec-18 6 9.38 10.06 9.00 23.13
Year Ending Dec-19 6 13.35 14.40 12.40 48.34
Earnings (per share)
Quarter Ending Dec-18 6 -0.38 -0.28 -0.57 -0.43
Quarter Ending Mar-19 5 -0.34 -0.28 -0.39 --
Year Ending Dec-18 6 -1.97 -1.86 -2.17 -1.67
Year Ending Dec-19 6 -1.30 -1.01 -1.69 -25.46

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 2.51 2.99 0.48 19.09
Quarter Ending Jun-18 3.26 2.73 0.52 16.12
Quarter Ending Mar-18 3.46 1.35 2.12 61.14
Quarter Ending Dec-17 3.89 3.69 0.20 5.08
Quarter Ending Sep-17 2.90 2.79 0.11 3.75

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 2.33 2.33 2.36 2.98 7.55
Quarter Ending Mar-19 2.72 2.72 2.72 3.00 1.60
Year Ending Dec-18 9.38 9.38 9.43 9.57 23.13
Year Ending Dec-19 13.35 13.35 13.35 14.91 48.34

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 0 1
Quarter Ending Mar-19 0 0 1 0
Year Ending Dec-18 0 0 1 1
Year Ending Dec-19 0 0 0 1
Earnings